Breaking News
FONT-SIZE Plus   Neg
Share SHARE

MetLife Upset With Federal Reserve Over Stress Test Results - Update

RELATED NEWS
Trade MET now with 

MetLife Inc. (MET: Quote) Tuesday played down the results from the latest round of stress tests by the Federal Reserve, stating that its financial position remained strong and is capable of meeting an adverse economic scenario.

The Federal Reserve earlier in the day revealed results from its stress tests, or Comprehensive Capital Analysis and Review, of 19 biggest U.S. banks, including MetLife, to assess their financial soundness to return more capital to shareholders.

Results from the tests showed that MetLife will not be able to maintain its core tier-one capital ratio at above 5 percent of risk-weighted assets, prompting the Federal Reserve to deny a request by the insurer for an increase in its capital distribution plan.

Expressing displeasure, MetLife CEO Steven Kandarian said that bank-centric methodologies used under the stress tests are unsuitable for insurance companies, which have a different business model.

Kandarian said that when gauged under methodologies apt for insurers, MetLife has an enviable financial position. He indicated that at the end of 2011, MetLife had a consolidated risk-based capital ratio of 450 percent.

In its capital plan submitted to the Federal Reserve, MetLife had requested for approval of $2 billion in stock repurchases and a raise in its annual common stock dividend to to $1.10 per share from $0.74 per share.

MetLife had excess capital of $3.5 billion at the end of 2011, and expects that to reach $6 billion to $7 billion by the end of 2012, before any capital distribution actions.

Apart from MetLife, the Federal Reserve said that Citigroup, SunTrust and Ally would all see their capital ratio fall below 5 percent if they went ahead with their capital plans. But most of the banks subject to the stress tests were allowed to raise dividends and buy back shares.

The Federal Reserve had asked these banks to evaluate their financial strength amid a global economy bogged down by recession and double-digit unemployment in the U.S. Only those banks that can prove their ability to maintain core capital levels above 5 per cent of risk-weighted assets are allowed to raise dividends and buy back shares.

J.P. Morgan Chase & Co. was the first institution to disclose its results. The bank said it would increase its quarterly dividend to 30 cents, and repurchase about $15 billion of stock over the next year.

MET closed Tuesday on the NYSE at $39.46, up $1.78 or 4.72%, on a volume of 12.2 million shares. In after hours, the stock dropped 3.7%.

Register
To receive FREE breaking news email alerts for MetLife Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.